Table 1.
Inflammatory mediators detected in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS)
Biomarker | Key finding | Reference(s) |
---|---|---|
Chit-1 | ↑ levels and ↑ activity | [48] |
↑ levels | [49] | |
Prostaglandin E2 | NC | [50] |
↑ levels | [51, 52] | |
VEGF | ↑ levels | [53] |
↓ levels | [50] | |
IL-6 | ↑ levels | [53, 54] |
GM-CSF | ↑ levels | [53] |
IL-2 | ↑ levels | [53] |
IL-15 | ↑ levels | [53] |
IL-17 | ↑ levels | [53] |
MIP-1β | ↑ levels | [53] |
FGF | ↑ levels | [53] |
G-CSF | ↑ levels | [53] |
MIP-1α | ↑ levels | [53] |
MCP-1 | ↑ levels | [53, 55] |
IL-10 | ↓ levels | [53] |
IFN-γ | ↓ levels | [53] |
IL-8 | ↑ levels | [55] |
Angiogenin | ↓ levels | [50] |
Angiopoietin 2 | NC | [50] |
Follistatin | ↓ levels | [56] |
IL-1α | ↓ levels | [56] |
Kallikrein-5 | ↓ levels | [56] |
↓ and ↑ represent decreased and increased levels in patients with ALS vs controls respectively
Chit-1 = chitotriosidase-1; NC = no change observed; VEGF = vascular endothelial growth factor; IL = interleukin; GM-CSF = granulocyte macrophage colony-stimulating factor; MIP = macrophage inflammatory protein; FGF = fibroblast growth factor; G-CSF = granulocyte colony-stimulating factor; MCP = monocyte chemoattractant protein 1; IFN = interferon